Skip to search formSkip to main contentSkip to account menu

sarilumab

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
— Für behandelnde Rheumatologen zählt in der Wahl einer Therapie neben deren anhaltender Wirksamkeit vor allem die… 
2018
2018
Sarilumab es un anticuerpo monoclonal que se une especificamente a los receptores de interleucina 6 (IL-6R), bloqueando la… 
2018
2018
Rheumatoid arthritis is a chronic, inflammatory and systemic disease that affects the peripheral joints, usually symmetrically… 
2018
2018
— Bei Hämophilie A besteht das A & O der medikamentösen Prophylaxe in adäquater Faktor-VIII-Substitution. Der rekombinante… 
2016
2016
For rheumatoid arthritis patients who cannot tolerate methotrexate, combination therapy isn't often an option. This study offers… 
2016
2016
Interleukin6 (IL6) a jeho rozpustný receptor jsou detekovany ve sklivci u pacientů s uveitidou. Studie faze 2 byla provedena s… 
2015
2015
IL-6 inhibitors sarilumab, an investigational drug, and tocilizumab, an established treatment in RA, are equally safe, shows two… 
2015
2015
Sarilumab with csDMARDS are safe and effective in rheumatoid arthritis patients after TNF failure or intolerance. 
2014
2014
Sanofi and Regeneron Pharmaceuticals presented positive results from a phase 3 trial of investigational drug sarilumab in…